Author

Danny Grannick

Danny Grannick is the CEO and co-founder of Bristle. He received his BA in Biochemistry from the University of San Diego. After receiving his degree, Danny moved into a variety of commercial roles at leading genomics companies including Illumina and Oxford Nanopore. His passion is in bridging the gap between innovation on the bench and implementation at the bedside.

Articles by

Danny Grannick

Bristle Raises $3M for First At-Home Oral Microbiome Test
Bristle announces the closing of their $3m seed round today, led by Initialized Capital, with investments from Y Combinator and Anne Wojcicki (CEO, 23andMe). Bristle helps people measure, understand, and improve oral health through the oral microbiome.
Read article
Oral health and cognitive decline
Research suggests that cognitive decline is connected to bacteria that cause gum disease. We'll explore the relationship between gum disease and Alzheimer's.
Read article
Providing patients a voice for oral health (pun intended)
We’re really excited about healthcare transformation! New diagnostics (like genomics), treatments (like immunotherapies), and technologies (like the phone in your pocket) are changing how healthcare is packaged and delivered. Simply put: we can reach more people, more personally, to provide better care.
Read article
About our test
Bristle identifies and quantifies all of the microbes in your mouth — over 150 different types of bacteria on average.
Read article
Why oral health and care?
We tend to view oral health as an accessory rather than as a critical component to our overall health.
Read article